These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16092795)

  • 1. The role of inflammation in the pathogenesis of acne and acne scarring.
    Holland DB; Jeremy AH
    Semin Cutan Med Surg; 2005 Jun; 24(2):79-83. PubMed ID: 16092795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar.
    Holland DB; Jeremy AH; Roberts SG; Seukeran DC; Layton AM; Cunliffe WJ
    Br J Dermatol; 2004 Jan; 150(1):72-81. PubMed ID: 14746619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal treatment of acne, acne scars and pigmentation.
    Shamban AT; Narurkar VA
    Dermatol Clin; 2009 Oct; 27(4):459-71, vi. PubMed ID: 19850195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrophic acne scar: a process from altered metabolism of elastic fibres and collagen fibres based on transforming growth factor-β1 signalling.
    Moon J; Yoon JY; Yang JH; Kwon HH; Min S; Suh DH
    Br J Dermatol; 2019 Dec; 181(6):1226-1237. PubMed ID: 30822364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acne: inflammation.
    Farrar MD; Ingham E
    Clin Dermatol; 2004; 22(5):380-4. PubMed ID: 15556722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of postacne scarring.
    Goodman GJ; Baron JA
    Dermatol Surg; 2007 Oct; 33(10):1175-88. PubMed ID: 17903150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of toll-like receptors in the pathophysiology of acne.
    McInturff JE; Kim J
    Semin Cutan Med Surg; 2005 Jun; 24(2):73-8. PubMed ID: 16092794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different cutaneous innate immunity profiles in acne patients with and without atrophic scars.
    Saint-Jean M; Khammari A; Jasson F; Nguyen JM; Dréno B
    Eur J Dermatol; 2016; 26(1):68-74. PubMed ID: 27018005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrophic scar formation in patients with acne involves long-acting immune responses with plasma cells and alteration of sebaceous glands.
    Carlavan I; Bertino B; Rivier M; Martel P; Bourdes V; Motte M; Déret S; Reiniche P; Menigot C; Khammari A; Dreno B; Fogel P; Voegel JJ
    Br J Dermatol; 2018 Oct; 179(4):906-917. PubMed ID: 29663317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acne scarring: a classification system and review of treatment options.
    Jacob CI; Dover JS; Kaminer MS
    J Am Acad Dermatol; 2001 Jul; 45(1):109-17. PubMed ID: 11423843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acne vulgaris and prevention of acne scarring: canadian consensus guidelines.
    Madden WS; Landells ID; Poulin Y; Searles GE; Smith KC; Tan JK; Toole J; Zip CM; Degreef H
    J Cutan Med Surg; 2000 Jun; 4 Suppl 1():S2-13. PubMed ID: 11749902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sequence of inflammation, relevant biomarkers, and the pathogenesis of acne vulgaris: what does recent research show and what does it mean to the clinician?
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Aug; 12(8 Suppl):s109-15. PubMed ID: 23986176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor levels in the sebaceous glands of papulopustular lesions from patients with Behçet's disease and acne vulgaris: a controlled study.
    Durusoy C; Alpsoy E; Elpek O; Karpuzoglu G
    Adv Clin Path; 2002 Apr; 6(2):87-93. PubMed ID: 19753730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-evaluating treatment targets in acne vulgaris: adapting to a new understanding of pathophysiology.
    Kircik LH
    J Drugs Dermatol; 2014 Jun; 13(6):s57-60. PubMed ID: 24918572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory events are involved in acne lesion initiation.
    Jeremy AH; Holland DB; Roberts SG; Thomson KF; Cunliffe WJ
    J Invest Dermatol; 2003 Jul; 121(1):20-7. PubMed ID: 12839559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acne and osteoarticular manifestations].
    Courouge-Dorcier D; Reguilhem O; Brucher C; Delaunay MM; Geniaux M
    Rev Rhum Mal Osteoartic; 1987 Oct; 54(10):637-42. PubMed ID: 2962267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonablative acne scar reduction after a series of treatments with a short-pulsed 1,064-nm neodymium:YAG laser.
    Lipper GM; Perez M
    Dermatol Surg; 2006 Aug; 32(8):998-1006. PubMed ID: 16918561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical evidence of chronic inflammation in acne vulgaris].
    Brănişteanu D; Cianga C; Cianga P; Petrescu Z; Carasevici E
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(2):319-24. PubMed ID: 15688807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of inflammatory facial acne vulgaris with combination 595-nm pulsed-dye laser with dynamic-cooling-device and 1,450-nm diode laser.
    Glaich AS; Friedman PM; Jih MH; Goldberg LH
    Lasers Surg Med; 2006 Mar; 38(3):177-80. PubMed ID: 16180221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel fractional resurfacing device for treatment of acne scarring.
    Walgrave SE; Ortiz AE; MacFalls HT; Elkeeb L; Truitt AK; Tournas JA; Zelickson BD; Zachary CB
    Lasers Surg Med; 2009 Feb; 41(2):122-7. PubMed ID: 19226575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.